Johnson & Johnson vs Eli Lilly and Company — Stock Comparison
Johnson & Johnson (JNJ) and Eli Lilly and Company (LLY) are both listed on US exchanges. This page compares their Q·Score ratings, key fundamentals (P/E, margins, growth), and Wall Street analyst consensus side by side. Data sourced from Yahoo Finance and updated on each page load.
Eli Lilly and Company clearly outscores Johnson & Johnson on Q·Score (7.7 vs 6.1 out of 10), led by Growth (9.8 vs 4.3) and Quality (9 vs 6.2). Johnson & Johnson scores higher on Health, reflecting stronger balance sheet strength. Analyst price targets imply similar upside for both: +5.9% for JNJ and +4.6% for LLY.
Price Performance
Normalised to 100 at period start — shows relative performance.
Q·Score Breakdown
70% of 23 covering analysts have a positive rating.
⚠ earnings contracting 96% year-over-year.
Earnings growing 26% year-over-year on 48% revenue growth.
Analyst Consensus
Fundamentals
Frequently Asked Questions
JNJ vs LLY: which stock scores better overall?
Based on Q·Score, Eli Lilly and Company (LLY) scores 7.7/10 versus Johnson & Johnson (JNJ) at 6.1/10. The Q·Score measures five dimensions: Quality, Health, Growth, Valuation, and Sentiment. For informational purposes only — not financial advice.
Which has better revenue growth: JNJ or LLY?
Eli Lilly and Company (LLY) scores higher on Growth (9.8/10 vs 4.3/10). Johnson & Johnson reports revenue growth (5.9% YoY) while Eli Lilly and Company reports (47.7% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.
Is JNJ or LLY more attractively valued?
Johnson & Johnson (JNJ) scores higher on Valuation (6.3/10 vs 5.8/10). JNJ trades at 22.7× P/E versus LLY at 27.0×. Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.
What do analysts say about JNJ vs LLY?
There are 22 analysts covering JNJ with a consensus price target of $279.41, and 30 analysts covering LLY with a consensus target of $1331.55. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.
Which is more profitable: JNJ or LLY?
Eli Lilly and Company (LLY) scores higher on Quality (9/10 vs 6.2/10). Net profit margin: JNJ at 16.2%, LLY at 33.5%. Quality scores reflect profit margins, return on equity, and free cash flow generation.
Which has stronger financial health: JNJ or LLY?
Johnson & Johnson (JNJ) scores higher on Financial Health (6.5/10 vs 5.5/10). Market beta: JNJ at 0.21, LLY at 0.45. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.
What are the market caps of JNJ and LLY?
Johnson & Johnson (JNJ) has a market capitalisation of $635.1B, while Eli Lilly and Company (LLY) has a market cap of $1.14T. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.
Do JNJ or LLY pay dividends?
JNJ pays a dividend yield of 2.00%, while LLY pays a dividend yield of 0.53%. Dividend yields fluctuate with share price and company payout decisions.
Related Comparisons
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →